Quantitative real time polymerase chain reaction (qRT‒PCR) and Western blotting experiments indicated that USP14 expression was significantly elevated in lenvatinib-resistant cell lines (Fig. 1d), as well as in 10 pairs of fresh tumor tissues from resistant patients and sensitive patients (Fig. 1e‒g). The gene discussed is USP14; the disease is neoplasm.